Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-7 of 7
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
1-Jun-2015The next steps in improving the outcomes of advanced ovarian cancerOpenshaw, MR; Fotopoulou, C; Blagden, S; Gabra, H
1-Mar-2015Risk of Ovarian Cancer Relapse Score A Prognostic Algorithm to Predict Relapse Following Treatment for Advanced Ovarian CancerRizzuto, I; Stavraka, C; Chatterjee, J; Borley, J; Hopkins, TG, et al
23-Oct-2015Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerBowtell, DD; Boehm, S; Ahmed, AA; Aspuria, P-J; Bast, RC, et al
23-Mar-2015The role of interleukin-8 (IL-8) and IL-8 receptors in platinum response in high grade serous ovarian carcinomaStronach, EA; Cunnea, P; Turner, C; Guney, T; Aiyappa, R, et al
1-Oct-2015Dose-finding quantitative F-18-FDG PET imaging study with the oral pan-AKT inhibitor GSK2141795 in patients with gynecologic malignanciesGungor, H; Saleem, A; Babar, S; Dina, R; El-Bahrawy, MA, et al
31-Jul-2015Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinomaMatsuo, K; Hasegawa, K; Yoshino, K; Murakami, R; Hisamatsu, T, et al
19-Oct-2015A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathwayCheraghchi-Bashi, A; Parker, CA; Curry, E; Salazar, J-F; Gungor, H, et al